OBJECTIVES: The incidence and severity of ulcerative colitis (UC) are highe
r in nonsmokers than in smokers. The natural course of UC in smokers who st
op smoking is not known. The aim of this study was to determine the impact
of cessation of smoking on the course of UC among the cohort of patients re
gularly seen at our institution.
METHODS: The severity of UC, as judged by the occurrence of flare-ups and t
he need for systemic steroids, immunosuppressive drugs and colectomy, was d
etermined in 32 patients with UC who stopped smoking after the diagnosis of
UC. We compared the period after cessation of smoking (7-yr mean follow-up
) with the period between the onset of the disease and the cessation of smo
king (9-yr mean duration). The course of UC in this group was compared with
that of 32 nonsmokers and 32 continuing smokers matched for sex, age, and
age at onset.
RESULTS: In patients who quit, cessation of smoking was followed by an incr
ease in the rate of years with active disease (p < 0.01), years with hospit
alization (p < 0.05) and years with major medical therapy (oral steroids, i
ntravenous steroids, and azathioprine, p < 0.01). After cessation of smokin
g, the rate of years with immunosuppressive therapy was significantly great
er in ex-smokers and nonsmokers than in continuing smokers (p < 0.01). The
risk of colectomy in ex-smokers after smoking cessation was similar to that
of nonsmokers and continuing smokers.
CONCLUSIONS: In smokers with UC who stop smoking, the severity of the disea
se increases after smoking cessation, with an increase in the disease activ
ity and the need for hospital admission and major medical therapy. In addit
ion, the need for azathioprine therapy becomes similar to that of nonsmoker
s.